Výsledky vyhľadávania - "LEFLUNOMIDE"
-
1
Autori: a ďalší
Zdroj: Frontiers in immunology [Front Immunol] 2025 Oct 17; Vol. 16, pp. 1566377. Date of Electronic Publication: 2025 Oct 17 (Print Publication: 2025).
Spôsob vydávania: Journal Article; Randomized Controlled Trial
Informácie o časopise: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Výrazy zo slovníka MeSH: Hydroxychloroquine*/therapeutic use , Hydroxychloroquine*/administration & dosage , Leflunomide*/therapeutic use , Leflunomide*/administration & dosage , Sjogren's Syndrome*/drug therapy , Sjogren's Syndrome*/immunology , Sjogren's Syndrome*/blood , Sjogren's Syndrome*/diagnosis , Sjogren's Syndrome*/metabolism , Interferon-gamma*, Humans ; Female ; Middle Aged ; Male ; Drug Therapy, Combination ; Biomarkers/blood ; Adult ; Treatment Outcome ; Proteomics/methods ; Aged ; Antirheumatic Agents/therapeutic use ; Proteome
-
2
Autori: a ďalší
Zdroj: European journal of pharmacology [Eur J Pharmacol] 2025 Nov 15; Vol. 1007, pp. 178267. Date of Electronic Publication: 2025 Oct 16.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE
Výrazy zo slovníka MeSH: Proto-Oncogene Proteins c-akt*/metabolism , Toll-Like Receptor 4*/metabolism , Leflunomide*/adverse effects , Phosphatidylinositol 3-Kinases*/metabolism , Pramipexole*/pharmacology , Dopamine Agonists*/pharmacology , Dopamine Agonists*/therapeutic use , Kidney*/drug effects , Kidney*/pathology , Kidney*/metabolism, Animals ; Mice ; Male ; Inflammation/drug therapy ; Inflammation/metabolism ; Oxidative Stress/drug effects ; Signal Transduction/drug effects ; Apoptosis/drug effects ; Mice, Inbred C57BL
-
3
Autori: a ďalší
Zdroj: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2025 Sep; Vol. 214, pp. 114808. Date of Electronic Publication: 2025 Jul 09.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3441 (Electronic) Linking ISSN: 09396411 NLM ISO Abbreviation: Eur J Pharm Biopharm Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/administration & dosage , Leflunomide*/pharmacokinetics , Chitosan*/chemistry , Arthritis, Rheumatoid*/drug therapy , Nanoparticles*/chemistry , Silicon Dioxide*/chemistry , Polylactic Acid-Polyglycolic Acid Copolymer*/chemistry , Folic Acid*/chemistry , Antirheumatic Agents*/administration & dosage, Animals ; Rats ; Drug Liberation ; Male ; Drug Carriers/chemistry ; Particle Size ; Drug Delivery Systems/methods ; Arthritis, Experimental/drug therapy ; Porosity ; Rats, Sprague-Dawley ; Biological Availability ; Surface Properties ; Administration, Oral
-
4
Autori: a ďalší
Zdroj: International journal of molecular sciences [Int J Mol Sci] 2025 Jul 15; Vol. 26 (14). Date of Electronic Publication: 2025 Jul 15.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Výrazy zo slovníka MeSH: Vitiligo*/drug therapy , Vitiligo*/immunology , Vitiligo*/pathology , Vitiligo*/metabolism , Leflunomide*/pharmacology , Leflunomide*/therapeutic use , Immunomodulation*/drug effects, Animals ; Mice ; Disease Models, Animal ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/drug effects ; Cytokines/metabolism ; Disease Progression ; Chemokine CXCL9/metabolism ; Interferon-gamma/metabolism
-
5
Autori: a ďalší
Zdroj: Pharmaceutical development and technology [Pharm Dev Technol] 2025 Jul; Vol. 30 (6), pp. 863-874. Date of Electronic Publication: 2025 Jun 30.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9610932 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-9867 (Electronic) Linking ISSN: 10837450 NLM ISO Abbreviation: Pharm Dev Technol Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/administration & dosage , Leflunomide*/chemistry , Leflunomide*/pharmacology , Leflunomide*/pharmacokinetics , Anti-Inflammatory Agents, Non-Steroidal*/administration & dosage, Animals ; Rats ; Rats, Wistar ; Particle Size ; Gels/chemistry ; Drug Liberation ; Skin Absorption/drug effects ; Male ; Drug Carriers/chemistry ; Cellulose/chemistry ; Cellulose/analogs & derivatives ; Skin/drug effects ; Skin/metabolism ; Administration, Cutaneous ; Delayed-Action Preparations
-
6
Autori: a ďalší
Korporácia: a ďalší
Zdroj: British journal of clinical pharmacology [Br J Clin Pharmacol] 2025 Jun; Vol. 91 (6), pp. 1586-1599. Date of Electronic Publication: 2024 Apr 08.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/adverse effects , Leflunomide*/therapeutic use , Leflunomide*/administration & dosage , COVID-19*/epidemiology , Antirheumatic Agents*/adverse effects , Antirheumatic Agents*/therapeutic use , Antirheumatic Agents*/administration & dosage , Drug Monitoring*/statistics & numerical data , Drug Monitoring*/methods , Azathioprine*/adverse effects , Azathioprine*/therapeutic use , Azathioprine*/administration & dosage , Methotrexate*/adverse effects , Methotrexate*/therapeutic use , Methotrexate*/administration & dosage, Humans ; Female ; Male ; Aged ; Middle Aged ; Adult ; Cohort Studies ; COVID-19 Drug Treatment ; Electronic Health Records ; SARS-CoV-2 ; Young Adult
-
7
Autori: a ďalší
Zdroj: Scientific reports [Sci Rep] 2025 Apr 05; Vol. 15 (1), pp. 11703. Date of Electronic Publication: 2025 Apr 05.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/pharmacology , Prolactinoma*/drug therapy , Prolactinoma*/genetics , Prolactinoma*/pathology , Prolactinoma*/metabolism , Pituitary Neoplasms*/drug therapy , Pituitary Neoplasms*/genetics , Pituitary Neoplasms*/pathology , Pituitary Neoplasms*/metabolism , Transcriptome* , Antineoplastic Agents*/pharmacology, Animals ; Rats ; Cell Line, Tumor ; Gene Expression Profiling ; Cell Proliferation/drug effects ; Cabergoline/pharmacology ; Gene Expression Regulation, Neoplastic/drug effects ; Apoptosis/drug effects ; Protein Interaction Maps/drug effects ; Male
-
8
Autori: a ďalší
Zdroj: Turkish journal of medical sciences [Turk J Med Sci] 2025 Mar 24; Vol. 55 (3), pp. 632-643. Date of Electronic Publication: 2025 Mar 24 (Print Publication: 2025).
Spôsob vydávania: Journal Article; Comparative Study
Informácie o časopise: Publisher: Scientific and Technical Research Council of Turkey Country of Publication: Turkey NLM ID: 9441758 Publication Model: eCollection Cited Medium: Internet ISSN: 1303-6165 (Electronic) Linking ISSN: 13000144 NLM ISO Abbreviation: Turk J Med Sci Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/therapeutic use , Leflunomide*/adverse effects , Leflunomide*/administration & dosage , Methotrexate*/therapeutic use , Methotrexate*/adverse effects , Methotrexate*/administration & dosage , Arthritis, Psoriatic*/drug therapy , Arthritis, Rheumatoid*/drug therapy , Antirheumatic Agents*/therapeutic use , Antirheumatic Agents*/adverse effects , Antirheumatic Agents*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Drug Therapy, Combination ; Adult ; Aged ; Treatment Outcome ; Isoxazoles ; Retrospective Studies
-
9
Autori: a ďalší
Zdroj: Combinatorial chemistry & high throughput screening [Comb Chem High Throughput Screen] 2025; Vol. 28 (11), pp. 1815-1831.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9810948 Publication Model: Print Cited Medium: Internet ISSN: 1875-5402 (Electronic) Linking ISSN: 13862073 NLM ISO Abbreviation: Comb Chem High Throughput Screen Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/pharmacology , Leflunomide*/chemistry , Molecular Docking Simulation* , Methotrexate*/pharmacology , Methotrexate*/chemistry , Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/metabolism , Network Pharmacology* , Antirheumatic Agents*/pharmacology , Antirheumatic Agents*/chemistry, Humans ; Animals ; Drug Therapy, Combination
-
10
Autori: a ďalší
Zdroj: Current drug safety [Curr Drug Saf] 2025; Vol. 20 (3), pp. 388-393.
Spôsob vydávania: Case Reports; Journal Article
Informácie o časopise: Publisher: Saif Zone, Sharjah, U.A.E. Country of Publication: United Arab Emirates NLM ID: 101270895 Publication Model: Print Cited Medium: Internet ISSN: 2212-3911 (Electronic) Linking ISSN: 15748863 NLM ISO Abbreviation: Curr Drug Saf Subsets: MEDLINE
Výrazy zo slovníka MeSH: Drug Hypersensitivity Syndrome*/etiology , Drug Hypersensitivity Syndrome*/diagnosis , Leflunomide*/adverse effects , Leflunomide*/administration & dosage , Cefuroxime*/adverse effects , Cefuroxime*/administration & dosage , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/administration & dosage, Humans ; Female ; Adult ; Eosinophilia/chemically induced
-
11
Autori: a ďalší
Zdroj: Nature communications [Nat Commun] 2025 Mar 19; Vol. 16 (1), pp. 2651. Date of Electronic Publication: 2025 Mar 19.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/pharmacology , Leflunomide*/therapeutic use , Cardiotoxicity*/prevention & control , Cardiotoxicity*/etiology , Cardiotoxicity*/metabolism , Gastrointestinal Microbiome*/drug effects , Indoles*/pharmacology , Indoles*/metabolism , Programmed Cell Death 1 Receptor*/antagonists & inhibitors , Heart*/drug effects , Propionates*/metabolism , Propionates*/pharmacology, Animals ; Mice ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/metabolism ; Mice, Inbred C57BL ; Male ; Receptors, Aryl Hydrocarbon/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Fecal Microbiota Transplantation ; Immune Checkpoint Inhibitors/adverse effects
-
12
Autori: a ďalší
Zdroj: Acta neurobiologiae experimentalis [Acta Neurobiol Exp (Wars)] 2025 Jan 14; Vol. 84 (4), pp. 319-331. Date of Electronic Publication: 2025 Jan 14.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: Nencki Institute of Experimental Biology Country of Publication: Poland NLM ID: 1246675 Publication Model: Electronic Cited Medium: Internet ISSN: 1689-0035 (Electronic) Linking ISSN: 00651400 NLM ISO Abbreviation: Acta Neurobiol Exp (Wars) Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/pharmacology , Leflunomide*/therapeutic use , Neuroprotective Agents*/pharmacology , Neuroprotective Agents*/therapeutic use , Parkinsonian Disorders*/drug therapy , MPTP Poisoning*/drug therapy, Animals ; Mice ; Male ; Disease Models, Animal ; Motor Activity/drug effects ; Mice, Inbred C57BL ; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/pharmacology
-
13
Autori: a ďalší
Zdroj: BMJ case reports [BMJ Case Rep] 2025 Jan 29; Vol. 18 (1). Date of Electronic Publication: 2025 Jan 29.
Spôsob vydávania: Journal Article; Case Reports
Informácie o časopise: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE
Výrazy zo slovníka MeSH: Antirheumatic Agents*/adverse effects , Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/complications , Drug Hypersensitivity Syndrome*/etiology , Drug Hypersensitivity Syndrome*/diagnosis , Drug Hypersensitivity Syndrome*/drug therapy , Drug Hypersensitivity Syndrome*/complications , Leflunomide*/adverse effects , Lymphohistiocytosis, Hemophagocytic*/chemically induced , Lymphohistiocytosis, Hemophagocytic*/complications , Lymphohistiocytosis, Hemophagocytic*/drug therapy , Lymphohistiocytosis, Hemophagocytic*/diagnosis, Female ; Humans ; Middle Aged ; Hydroxychloroquine/adverse effects ; Hydroxychloroquine/therapeutic use ; Isoxazoles/adverse effects ; Piperidines/therapeutic use ; Pyrimidines/therapeutic use
-
14
Autori: a ďalší
Zdroj: The Annals of otology, rhinology, and laryngology [Ann Otol Rhinol Laryngol] 2024 Oct; Vol. 133 (10), pp. 898-901. Date of Electronic Publication: 2024 Jul 25.
Spôsob vydávania: Journal Article; Case Reports
Informácie o časopise: Publisher: Sage Country of Publication: United States NLM ID: 0407300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-572X (Electronic) Linking ISSN: 00034894 NLM ISO Abbreviation: Ann Otol Rhinol Laryngol Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/adverse effects , Leflunomide*/therapeutic use , Cochlear Implantation*/adverse effects , Surgical Wound Dehiscence*/chemically induced , Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/surgery , Immunosuppressive Agents*/adverse effects, Humans ; Male ; Aged, 80 and over ; Surgical Wound Infection ; Antirheumatic Agents/adverse effects
-
15
Autori: a ďalší
Zdroj: International journal of pharmaceutics [Int J Pharm] 2024 Dec 25; Vol. 667 (Pt A), pp. 124882. Date of Electronic Publication: 2024 Oct 28.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE
Výrazy zo slovníka MeSH: Arthritis, Rheumatoid*/drug therapy , Gold*/chemistry , Gold*/administration & dosage , Leflunomide*/administration & dosage , Arthritis, Experimental*/drug therapy , Sulfhydryl Compounds*/chemistry , Sulfhydryl Compounds*/administration & dosage, Animals ; RAW 264.7 Cells ; Mice ; Rats ; Male ; Albumins/administration & dosage ; Albumins/chemistry ; Antirheumatic Agents/administration & dosage ; Antirheumatic Agents/pharmacokinetics ; Antirheumatic Agents/chemistry ; Antirheumatic Agents/pharmacology ; Nanoparticles ; Drug Liberation ; Laser Therapy/methods ; Rats, Sprague-Dawley ; Disease Models, Animal
-
16
Autori:
Zdroj: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Dec; Vol. 32 (10), pp. 2572-2574. Date of Electronic Publication: 2024 Jul 25.
Spôsob vydávania: Case Reports; Journal Article
Informácie o časopise: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/therapeutic use , Conjunctivitis, Allergic*/drug therapy , Conjunctivitis, Allergic*/diagnosis, Humans ; Male ; Middle Aged ; Immunosuppressive Agents/therapeutic use ; Visual Acuity
-
17
Autori: Zewail M; Department of Pharmaceutics, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.
Zdroj: Journal of microencapsulation [J Microencapsul] 2024 Dec; Vol. 41 (8), pp. 715-738. Date of Electronic Publication: 2024 Sep 25.
Spôsob vydávania: Journal Article; Review
Informácie o časopise: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8500513 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5246 (Electronic) Linking ISSN: 02652048 NLM ISO Abbreviation: J Microencapsul Subsets: MEDLINE
Výrazy zo slovníka MeSH: Leflunomide*/chemistry , Leflunomide*/therapeutic use , Leflunomide*/pharmacology , Leflunomide*/pharmacokinetics , Hydroxybutyrates*/chemistry , Antirheumatic Agents*/administration & dosage , Antirheumatic Agents*/pharmacokinetics , Antirheumatic Agents*/chemistry , Antirheumatic Agents*/therapeutic use , Antirheumatic Agents*/pharmacology , Toluidines*/chemistry , Toluidines*/therapeutic use , Toluidines*/pharmacokinetics, Humans ; Animals ; Nanoparticles/chemistry ; Nitriles/chemistry ; Drug Carriers/chemistry ; Crotonates/chemistry ; Crotonates/therapeutic use ; Arthritis, Rheumatoid/drug therapy ; Neoplasms/drug therapy ; Multiple Sclerosis/drug therapy ; Isoxazoles/chemistry ; Isoxazoles/pharmacokinetics ; Isoxazoles/pharmacology ; Isoxazoles/therapeutic use
-
18
Autori: a ďalší
Zdroj: The British journal of dermatology [Br J Dermatol] 2025 Oct 17; Vol. 193 (5), pp. 936-947.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Výrazy zo slovníka MeSH: Skin Neoplasms*/drug therapy , Skin Neoplasms*/metabolism , Skin Neoplasms*/pathology , Oxidoreductases Acting on CH-CH Group Donors*/antagonists & inhibitors , Oxidoreductases Acting on CH-CH Group Donors*/metabolism , Carcinoma, Squamous Cell*/drug therapy , Carcinoma, Squamous Cell*/metabolism , Carcinoma, Squamous Cell*/pathology , Enzyme Inhibitors*/pharmacology , Enzyme Inhibitors*/therapeutic use, Dihydroorotate Dehydrogenase ; Humans ; Animals ; Leflunomide/pharmacology ; Xenograft Model Antitumor Assays ; Proteomics ; Female ; Mice ; Male
-
19
Autori: a ďalší
Zdroj: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2025 Oct; Vol. 12 (38), pp. e04414. Date of Electronic Publication: 2025 Aug 13.
Spôsob vydávania: Journal Article
Informácie o časopise: Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE
Výrazy zo slovníka MeSH: Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/metabolism , Arthritis, Rheumatoid*/blood , Arthritis, Rheumatoid*/diagnosis , Biomarkers*/blood , Biomarkers*/metabolism , Metabolomics*/methods, Humans ; Male ; Female ; Longitudinal Studies ; Middle Aged ; Antirheumatic Agents/therapeutic use ; Adult ; Methotrexate/therapeutic use ; Severity of Illness Index ; Aged ; Treatment Outcome ; Hydroxychloroquine/therapeutic use ; Leflunomide/therapeutic use
-
20
Autori: a ďalší
Zdroj: Yonsei medical journal [Yonsei Med J] 2024 Nov; Vol. 65 (11), pp. 645-650.
Spôsob vydávania: Journal Article; Observational Study
Informácie o časopise: Publisher: Yonsei University Country of Publication: Korea (South) NLM ID: 0414003 Publication Model: Print Cited Medium: Internet ISSN: 1976-2437 (Electronic) Linking ISSN: 05135796 NLM ISO Abbreviation: Yonsei Med J Subsets: MEDLINE
Výrazy zo slovníka MeSH: COVID-19*/epidemiology , COVID-19*/complications , Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/complications , Arthritis, Rheumatoid*/epidemiology , Reinfection*/epidemiology , SARS-CoV-2* , Leflunomide*/therapeutic use, Humans ; Female ; Middle Aged ; Male ; Retrospective Studies ; Risk Factors ; Aged ; Prevalence ; Antirheumatic Agents/therapeutic use ; Antirheumatic Agents/adverse effects ; Proportional Hazards Models ; Republic of Korea/epidemiology ; Methotrexate/therapeutic use
SCR Disease Name: COVID-19 reinfection
Full Text Finder
Nájsť tento článok vo Web of Science